RSS   Newsletter   Contact   Advertise with us
Post Online Media

Noah D. Beerman EVP, US president at POXEL

Share on Twitter Share on LinkedIn
Staff writer | Lyon, France |
Noah D. BeermanMay 20, 2015, Lyon, France - POXEL SA, a biopharmaceutical company, announced that Noah D. Beerman has joined the company as executive vice president of business development and president of US Operations.
Mr. Beerman has been an executive in the biopharmaceutical industry for more than 25 years and draws on both research and business development experience from his early career, beginning at Repligen, Sandoz, Curis, and Technology Management & Funding.

It was at Indevus Pharmaceuticals from 1997 to 2009, where Mr. Beerman was responsible for multiple licensing, co-promotion and M&A agreements, that he established an industry-leading profile in corporate development as Chief Business Officer for the company.

From 2009-2011, Mr. Beerman was President, CEO, and Director of RXI Pharmaceuticals (now Galena BioPharma), and until 2013 Executive Vice President and Chief Operating Officer atCoronado Biosciences. Most recently he has served as an executive consultant in the biopharmaceutical industry, and Director on the Board of Trasir Therapeutics.

Mr. Beerman holds an MBA from Northeastern University’s High Technology Program and a Bachelors of Science in molecular genetics from the University of Rochester.


POST Online Media Contact